Nandrolone
Anabolic-Androgenic Steroid | Joint & Collagen Support
Community Research
Join others researching Nandrolone — share findings, ask questions, and learn from real experiences
Nandrolone is a synthetic 19-nortestosterone anabolic-androgenic steroid that has been in clinical use since the 1960s. Structurally, it differs from testosterone by the absence of a methyl group at the C19 position, which significantly reduces its androgenic activity relative to its anabolic potency. Nandrolone decanoate (Deca-Durabolin) was FDA-approved for the treatment of anemia associated with chronic renal failure and has also been used clinically for osteoporosis, wasting diseases, and severe burn recovery. Among anabolic steroids, nandrolone is particularly valued for its positive effects on collagen synthesis, joint health, and bone mineral density. It has one of the most favorable anabolic-to-androgenic ratios of any synthetic steroid (approximately 125:37 compared to testosterone at 100:100), making it a frequent choice for individuals seeking muscle growth with reduced androgenic side effects. Nandrolone is available in two primary ester formulations: the long-acting decanoate ester and the shorter-acting phenylpropionate ester (NPP).
Nandrolone binds to the androgen receptor (AR) with affinity comparable to testosterone, promoting nitrogen retention, protein synthesis, and satellite cell activation in skeletal muscle tissue. Its anabolic effects are mediated through AR-dependent gene transcription that upregulates muscle-specific proteins including myosin heavy chain and IGF-1. A key distinguishing feature of nandrolone is its interaction with 5-alpha reductase: unlike testosterone, which is converted to the more potent androgen dihydrotestosterone (DHT), nandrolone is reduced to dihydronandrolone (DHN), a weaker androgen. This results in lower androgenic activity in tissues rich in 5-alpha reductase (skin, prostate, hair follicles). Nandrolone also stimulates collagen synthesis and bone mineral content through direct effects on osteoblasts and fibroblasts, contributing to its well-documented benefits for joint and connective tissue health. It exhibits moderate progestogenic activity, binding to the progesterone receptor at approximately 20% the affinity of progesterone, which can influence prolactin levels and contribute to progesterone-related side effects. Nandrolone aromatizes to estradiol at roughly 20% the rate of testosterone, resulting in lower but not absent estrogenic activity.
Molecular Data
Research Indications
FDA-approved indication. Nandrolone decanoate stimulates erythropoietin production and directly enhances erythropoiesis, increasing red blood cell mass in patients with chronic kidney disease-associated anemia. Used particularly in patients who respond poorly to erythropoiesis-stimulating agents.
Historical use in aplastic anemia to stimulate red blood cell, white blood cell, and platelet production. Largely superseded by modern therapies but still considered in resource-limited settings.
Nandrolone increases collagen synthesis (type I and III), synovial fluid production, and overall connective tissue integrity. Widely reported to reduce joint pain and improve function in individuals with degenerative joint conditions or training-related joint stress. The mechanism involves direct stimulation of fibroblast activity and increased procollagen mRNA expression.
Nandrolone has been studied for the treatment and prevention of osteoporosis, particularly in postmenopausal women and hypogonadal men. It increases bone mineral density through direct osteoblast stimulation and suppression of osteoclast activity.
Used in HIV/AIDS-associated wasting, cancer cachexia, and chronic illness-related sarcopenia to preserve and restore lean body mass. Demonstrated significant improvements in lean mass, strength, and functional capacity in clinical trials.
Dose-dependent increases in lean body mass and muscle cross-sectional area. At therapeutic and supraphysiological doses, nandrolone promotes substantial gains in skeletal muscle with less water retention than equianabolic doses of testosterone.
Increases in maximal strength across compound movements, driven by enhanced protein synthesis, nitrogen retention, and glycogen storage. Effects are dose-dependent and most pronounced when combined with resistance training.
Nandrolone has been used to accelerate recovery from major surgery, severe burns, and debilitating injuries by promoting positive nitrogen balance, collagen deposition, and lean tissue preservation during catabolic states.
Preclinical evidence suggests nandrolone may enhance tendon healing by increasing collagen fiber organization and cross-linking. Clinical applications for tendon repair remain investigational but are supported by its known collagen-stimulating properties.
Dosing Protocols
Nandrolone is administered exclusively via intramuscular injection. Two ester formulations are available: nandrolone decanoate (Deca-Durabolin), a long-acting ester that permits weekly or biweekly dosing, and nandrolone phenylpropionate (NPP), a shorter ester requiring injections every 2-3 days. Decanoate is more common in clinical and performance settings due to its convenient dosing schedule, while NPP is preferred by those who want faster clearance and more rapid dose adjustments.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| TRT Adjunct - Joint Support | 50-100 mg/week | 1x per week (decanoate) | Intramuscular |
| Therapeutic - Anemia / Wasting | 100-200 mg/week | 1x per week (decanoate) | Intramuscular |
| Performance Enhancement - Moderate | 200-400 mg/week | 1x per week (decanoate) or split into 2 injections | Intramuscular |
| NPP Protocol - Shorter Cycle | 200-350 mg/week | Every other day or 3x per week | Intramuscular |
Reconstitution Instructions
- Pre-filled nandrolone vial (typically 100-200 mg/mL in sesame or arachis oil)
- Syringes (1 mL or 3 mL)
- Drawing needle (18-21 gauge)
- Injection needle (22-25 gauge for IM)
- Alcohol swabs
- Sharps container
- 1 Wash hands thoroughly and prepare a clean work surface
- 2 Wipe vial stopper with alcohol swab and allow to dry
- 3 Draw air into syringe equal to the volume of nandrolone to be withdrawn
- 4 Insert drawing needle through vial stopper and inject air to equalize pressure
- 5 Invert vial and withdraw the prescribed dose, tapping to remove air bubbles
- 6 Switch to injection needle (do not inject with drawing needle)
- 7 Clean injection site with alcohol swab in circular motion outward
- 8 Insert needle at 90-degree angle into ventrogluteal, vastus lateralis, or deltoid muscle
- 9 Aspirate briefly (optional per current guidelines), then inject slowly over 10-30 seconds
- 10 Withdraw needle, apply gentle pressure with gauze, dispose of needle in sharps container
Interactions
What to Expect
Side Effects & Safety
Common Side Effects
- Suppression of natural testosterone production (profoundly suppressive, more so than testosterone alone)
- Water retention and bloating (less than testosterone at equianabolic doses)
- Erectile dysfunction and reduced libido without concurrent testosterone ('deca dick')
- Increased appetite and weight gain
- Mild acne and oily skin (less pronounced than testosterone)
- Elevated hematocrit and hemoglobin (erythrocytosis)
- Injection site pain or discomfort
- Mild mood changes (some users report increased emotional sensitivity)
Stop Signs - Discontinue if:
- Severe chest pain, tightness, or pressure
- Sudden shortness of breath or difficulty breathing at rest
- Swelling, warmth, or pain in one leg (potential deep vein thrombosis)
- Severe or persistent headaches with visual disturbances
- Yellowing of skin or eyes (jaundice)
- Signs of stroke: sudden numbness, confusion, trouble speaking, loss of coordination
- Breast discharge or significant gynecomastia progression
- Persistent severe depression or suicidal ideation
Contraindications
- Prostate cancer (active or history of hormone-sensitive prostate cancer)
- Breast cancer in males or females
- Pregnancy or potential for pregnancy (Category X - causes virilization of female fetus)
- Nephrosis or the nephrotic phase of nephritis
- Severe hepatic impairment
- Hypercalcemia
- Known hypersensitivity to nandrolone or any formulation components
- Polycythemia (hematocrit above 54% at baseline)
- Uncontrolled heart failure or severe cardiovascular disease
Quality Checklist
Good Signs
- Clear, pale yellow to yellow oil with no visible particles or cloudiness
- Pharmaceutical-grade product with valid lot number and manufacturer identification
- Proper labeling with concentration (typically 100 or 200 mg/mL), ester type, and expiration date
- Intact rubber stopper with no signs of prior puncture
- Oil draws smoothly with appropriate viscosity (carrier oils: sesame, arachis/peanut, or castor oil)
- Prescribed by licensed physician with documented clinical indication
Warning Signs
- Underground lab (UGL) product without pharmaceutical-grade verification
- Concentration claims above 300 mg/mL (higher concentrations often cause severe post-injection pain)
- Vial label with spelling errors, misaligned printing, or unprofessional appearance
- Oil appears slightly darker than expected but is otherwise clear
- Product labeled as nandrolone but carrier oil is unidentified
Bad Signs
- Cloudy, discolored, or particulate-containing solution (contamination risk)
- Crashed product (crystallized steroid visible in vial)
- Broken or missing tamper-evident seal on vial
- No labeling, incorrect labeling, or missing expiration date
- Pain, redness, or swelling at injection site lasting more than 72 hours (potential infection or abscess)
- Product sourced without any testing or third-party verification
- Allergic reaction at injection site in patients with peanut allergy (arachis oil carrier)
References
- Nandrolone Decanoate: Pharmacological Properties and Therapeutic Use in OsteoporosisGeusens, P.Clinical Rheumatology (1995)
Comprehensive review of nandrolone decanoate's pharmacology and clinical efficacy in osteoporosis, demonstrating significant increases in bone mineral density and reductions in fracture risk. Documented nandrolone's favorable anabolic-to-androgenic ratio and its collagen-stimulating properties.
- Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case seriesBerns, J.S., Rudnick, M.R., Cohen, R.M.BMC Nephrology (2005)
Case series demonstrating nandrolone decanoate's efficacy in treating erythropoietin-refractory anemia in chronic kidney disease patients. Patients showed significant improvements in hemoglobin levels, supporting nandrolone's FDA-approved indication for renal anemia.
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal MenBhasin, S., Storer, T.W., Berman, N., et al.The New England Journal of Medicine (1996)
Landmark study establishing dose-dependent anabolic effects of supraphysiological androgens on muscle size and strength. While focused on testosterone, this trial provided the foundational framework for understanding anabolic steroid dose-response relationships applicable to nandrolone.
- Anabolic steroid-induced tendon pathology: a review of the literatureKanayama, G., DeLuca, J., Meehan, W.P., et al.Medicine and Science in Sports and Exercise (2015)
Review examining the effects of anabolic steroids on tendon structure and function. Found that nandrolone, unlike many other anabolic steroids, may have beneficial effects on collagen synthesis and tendon healing, consistent with its clinical reputation for joint and connective tissue support.
- Nandrolone decanoate: use, abuse and side effectsTamaki, T., Shiraishi, T., Takeda, H., et al.Medicina (Kaunas) (2003)
Comprehensive review of nandrolone decanoate covering its clinical applications, mechanisms of action, and side effect profile. Documented the compound's progestogenic activity, its interaction with 5-alpha reductase, and the importance of concurrent testosterone to prevent sexual dysfunction.
Related Peptides
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.